Jiao Shen

5PUBLICATIONS
98CO-AUTHORS
Haematological tumoursBiologically active moleculesMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 25, 2026
Activation-dependent lentiviruses enable antigen-specific T cell expansion and transduction.

|Feb 19, 2026
Rewiring STAT signaling from the cell surface with Trikine immunotherapeutics.

Grayson E Rodriguez, Yang Zhao, Yoko Nishiga

|Jun 12, 2025
Discovery of BMS-986408, a First-In-Class Dual DGKα and DGKζ Inhibitor that Unleashes PD-1 Checkpoint and CAR T-cell Immunotherapies.

Michael Wichroski, Si-Qi Liu, Lauren M Zasadil

|Jun 03, 2024
Anti-PD-1 cis-delivery of low-affinity IL-12 activates intratumoral CD8+T cells for systemic antitumor responses.

Zhuangzhi Zou, Jiao Shen, Diyuan Xue

|Sep 27, 2022
An engineered concealed IL-15-R elicits tumor-specific CD8+T cell responses through PD-1-cis delivery.

Jiao Shen, Zhuangzhi Zou, Jingya Guo

Pageof 1

Frequent Collaborators

3 joint publications

Stephanie K Dougan

2 joint publications

Hua Peng

2 joint publications

Yang-Xin Fu

2 joint publications

Michael Dougan